Trial intelligence / Profile preview

Clinical Pharmacology Study of Z-100 in Healthy Adults

jRCT2080221848Phase 1

Sponsor
Zeria Pharmaceutical Co., Ltd.
Start
Jul 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of Z-100 (5 arms), sponsored by Zeria Pharmaceutical Co., Ltd. Primary endpoint: Immunological parameters.

02

Drugs

Z-100

Beyond the preview

Go deeper on jRCT2080221848.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080221848.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call